Federal contract award
75F40119C10135
BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AZ12 — OTHER RESEARCH AND DEVELOPMENT - APPLIED RESEARCH/EXPLORATORY DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $2.7M |
| Current contract value | $2.7M |
| Potential contract value / ceiling | $2.7M |
| Start date | Sep 30, 2019 |
| Current end date | Sep 29, 2025 |
| Potential end date | Sep 29, 2025 |
| Latest award activity | Oct 30, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 30, 2025 | P00009 | $-18.0K | THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT. |
| Jul 1, 2025 | P00008 | $0 | COR CHANGE |
| Dec 9, 2024 | P00007 | $0 | BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING |
| Apr 20, 2023 | P00006 | $2.0M | BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING |
| Mar 14, 2023 | P00005 | $-2.0M | BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING |
| Nov 10, 2022 | P00004 | $0 | BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING |
| Aug 27, 2022 | P00003 | $0 | BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING |
| Nov 22, 2021 | P00002 | $0 | EO14042 BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING |
| May 27, 2020 | P00001 | $0 | BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING |
| Sep 30, 2019 | 0 | $2.8M | BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.